ZA9610839B - Immunologically active mistletoe extract preparations - Google Patents

Immunologically active mistletoe extract preparations

Info

Publication number
ZA9610839B
ZA9610839B ZA9610839A ZA9610839A ZA9610839B ZA 9610839 B ZA9610839 B ZA 9610839B ZA 9610839 A ZA9610839 A ZA 9610839A ZA 9610839 A ZA9610839 A ZA 9610839A ZA 9610839 B ZA9610839 B ZA 9610839B
Authority
ZA
South Africa
Prior art keywords
immunologically active
extract preparations
mistletoe extract
level
mistletoe
Prior art date
Application number
ZA9610839A
Inventor
Wilfried Waechter
Klaus Witthohn
Original Assignee
Madaus Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus Ag filed Critical Madaus Ag
Publication of ZA9610839B publication Critical patent/ZA9610839B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention relates to pharmaceutical preparations from mistletoe extracts with an immunologically active level of mistletoe lectin which obtain a high level of transit time stability due to stabilising additives. The stable preparations are adjusted to a level of mistletoe lectin which is the lowest possible to avoid side effects but has an optimal effect.
ZA9610839A 1995-12-27 1996-12-23 Immunologically active mistletoe extract preparations ZA9610839B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19548367A DE19548367A1 (en) 1995-12-27 1995-12-27 Immunologically effective mistletoe extract preparations

Publications (1)

Publication Number Publication Date
ZA9610839B true ZA9610839B (en) 1997-06-27

Family

ID=7781171

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610839A ZA9610839B (en) 1995-12-27 1996-12-23 Immunologically active mistletoe extract preparations

Country Status (10)

Country Link
EP (1) EP0869811B1 (en)
AT (1) ATE273018T1 (en)
AU (1) AU1302997A (en)
CZ (1) CZ294604B6 (en)
DE (2) DE19548367A1 (en)
HU (1) HUP9903664A3 (en)
PL (1) PL186543B1 (en)
SK (1) SK285257B6 (en)
WO (1) WO1997024136A1 (en)
ZA (1) ZA9610839B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19752597A1 (en) * 1997-11-27 1999-06-10 Madaus Ag Use of lectin preparations in the fight against bladder cancer
EP1418800B1 (en) 2001-07-09 2007-05-09 University of Copenhagen Methods and cuttings for mass propagation of plant parasites
EP2314608A1 (en) * 2009-10-26 2011-04-27 EyeSense AG Stabilisation of biosensors for in vivo applications

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4221836A1 (en) * 1992-07-03 1994-01-05 Gabius Hans Joachim Prof Dr New mistletoe lectin - with immunomodulatory activity, useful for cancer adjuvant therapy
DE4242902A1 (en) * 1992-12-18 1994-06-23 Madaus Ag Process for the preparation of lectin concentrates from mistletoe extracts and standardized preparations prepared therefrom for increasing natural immune resistance and for use in tumor therapy
DE4341476A1 (en) * 1993-12-02 1995-06-08 Uwe Dr Pfueller Compsn. for studying and modulating cellular changes

Also Published As

Publication number Publication date
HUP9903664A2 (en) 2000-03-28
CZ206198A3 (en) 1998-10-14
SK285257B6 (en) 2006-10-05
PL327583A1 (en) 1998-12-21
PL186543B1 (en) 2004-01-30
EP0869811A1 (en) 1998-10-14
DE19548367A1 (en) 1997-07-03
EP0869811B1 (en) 2004-08-11
CZ294604B6 (en) 2005-02-16
DE59611058D1 (en) 2004-09-16
SK89998A3 (en) 1999-05-07
AU1302997A (en) 1997-07-28
ATE273018T1 (en) 2004-08-15
HUP9903664A3 (en) 2000-04-28
WO1997024136A1 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
GR3029500T3 (en) Methods for modulating the human sexual response
DK0758248T3 (en) Formulations for factor IX
DE69329425D1 (en) DOLASTATIN ANALOG
GR960100438A (en) New pesticides.
TW225534B (en)
AR029139A1 (en) STABILIZED INTERLEUQUINA 2
MY114389A (en) Aqueous risperidone formulations
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
ATE264681T1 (en) IMPROVED MEDICATIONS
GR3036760T3 (en) D-mannitol and its preparation
WO2000039083A3 (en) Pyrazole compounds and uses thereof
JO1704B1 (en) New active compounds
PT930904E (en) PHARMACEUTICAL AMPOLA
ZA9610839B (en) Immunologically active mistletoe extract preparations
NO921619L (en) ELECTRICAL INSTALLATION SYSTEM
BG102342A (en) Optical active derivative of phenylpyrimidine as an anlgesics
HUP0004362A2 (en) Parenteral formulations comprising carbamazepine or its derivatives
TR200002293T2 (en) Pharmaceutical compositions.
BG104452A (en) New derivatives of the methylenebisphosphonic acid
ES2054827T3 (en) USE OF ALKYL PHOSPHATES FOR THE STABILIZATION OF TIXOTROPIC COMPOSITIONS.
ES8402820A1 (en) 4-Diphenylmethyl-1-(oxoalkyl)imino)methyl-piperidines and their derivatives.
MX9705959A (en) Formulations for il-12
JPS52146521A (en) White balance stabilizing unit
JPS52110522A (en) Color television signal processing system